Skip to Main Content

Paper Details

Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
Neuropsychopharmacol Rep
2
2021
ADHD, MPH, Patients, atomoxetine, attention-deficit/hyperactivity disorder, children, guanfacine, methylphenidate, patients

Datasets

Release 1.2